Guggenheim reiterates Enliven Therapeutics stock rating on FDA alignment

Guggenheim has reaffirmed its investment opinion on Enliven Therapeutics related to FDA consistency, but the impact on the stock direction is limited and neutral.

View Source Article ↗

AI CATALYST SCORE50 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

ANALYSIS HISTORY

ELVN Analysis History (Last 30 Days)

Diagnosed At	Ticker	AI Score	Tier
2026-10-08 11:52:11	ELVN	50	Mid	View Report →
2026-10-07 03:19:36	ELVN	75	Mid	View Report →
2026-07-15 17:16:34	ELVN	85	Mid	View Report →

RELATED REPORTS

Related Theme Reports #biotech

Diagnosed At	Ticker	AI Score	Tier
2026-10-12 20:42:18	SNDX	50	Mid	View Report →
2026-10-12 20:15:11	NRIX	88	Mid	View Report →
2026-10-12 18:38:43	NKTR	65	Mid	View Report →
2026-10-12 17:03:53	AZN	45	Mid	View Report →
2026-10-12 15:13:48	BMY	45	Mid	View Report →
2026-10-12 14:27:30	MIRM	85	Mid	View Report →
2026-10-12 11:54:45	SNDX	60	Mid	View Report →
2026-10-12 11:20:22	BMY	84	Mid	View Report →
2026-10-12 09:05:56	BIIB	78	S-Class	View Report →
2026-10-11 21:23:14	MIRM	35	Row	View Report →
2026-10-11 16:45:25	MRK	55	Mid	View Report →
2026-10-11 16:11:22	BBIO	82	Mid	View Report →
2026-10-11 13:11:02	ZYME	35	Row	View Report →
2026-10-11 11:10:29	INSM	42	Row	View Report →
2026-10-11 08:45:43	ETON	30	Row	View Report →
2026-10-11 01:58:05	TWST	35	Row	View Report →
2026-10-11 00:12:02	UTHR	35	Row	View Report →
2026-10-10 22:48:32	MRK	65	Mid	View Report →
2026-10-10 19:28:19	ZYME	20	Row	View Report →
2026-10-10 08:26:54	ANAB	85	Mid	View Report →
2026-10-09 21:09:20	HIMS	55	Mid	View Report →
2026-10-09 21:03:55	MRNA	78	S-Class	View Report →
2026-10-09 20:17:07	PCVX	45	Mid	View Report →
2026-10-09 17:43:30	VRTX	78	Mid	View Report →
2026-10-09 15:11:18	LLY	60	Mid	View Report →
2026-10-09 04:08:40	UTHR	40	Row	View Report →
2026-10-08 17:38:59	NGNE	72	Mid	View Report →
2026-10-08 16:47:23	RCKT	65	Mid	View Report →
2026-10-08 16:05:20	EDIT	82	S-Class	View Report →
2026-10-08 15:28:31	ADCT	45	Mid	View Report →

View Full History for ELVN (Blueprint) →